Guo-Wei Xiong - Search Results

Year	Number of Results
2002	1
2004	1
2005	1
2007	1
2009	1
2010	4
2011	1
2013	3
2014	2
2015	5
2016	7
2018	3
2019	11
2020	5
2021	9
2022	13
2023	12
2024	4

1

Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial.

Wang K, Xiang YJ, Yu HM, Cheng YQ, Liu ZH, Qin YY, Shi J, Guo WX, Lu CD, Zheng YX, Zhou FG, Yan ML, Zhou HK, Liang C, Zhang F, Wei WJ, Lau WY, Li JJ, Liu YF, Cheng SQ. Wang K, et al. Among authors: guo wx. Nat Med. 2024 Mar;30(3):708-715. doi: 10.1038/s41591-023-02786-7. Epub 2024 Jan 19. Nat Med. 2024. PMID: 38242982 Clinical Trial.

2

Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy?

Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ. Yu LH, et al. Among authors: guo wx. Ann Surg Oncol. 2014 Mar;21(3):1010-5. doi: 10.1245/s10434-013-3320-z. Ann Surg Oncol. 2014. PMID: 24121884 Review.

3

Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial.

Wang K, Yu HM, Xiang YJ, Cheng YQ, Ni QZ, Guo WX, Shi J, Feng S, Zhai J, Cheng SQ. Wang K, et al. Among authors: guo wx. Future Oncol. 2023 May;19(15):1029-1035. doi: 10.2217/fon-2022-0189. Epub 2023 May 3. Future Oncol. 2023. PMID: 37132469

4

Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study.

Wang WJ, Liu ZH, Wang K, Yu HM, Cheng YQ, Xiang YJ, Feng JK, Zhou LP, Zhou HK, Pan WW, Guo WX, Shi J, Cheng SQ. Wang WJ, et al. Among authors: guo wx. Cancer Med. 2023 May;12(10):11513-11524. doi: 10.1002/cam4.5880. Epub 2023 Mar 31. Cancer Med. 2023. PMID: 36999793 Free PMC article.

5

A Double Suspension Technique for Laparoscopic Isolated Caudate Lobectomy.

Guo L, Zhu XY, Wu XB, Xue J, Sun JX, Shi J, Cheng SQ, Guo WX. Guo L, et al. Among authors: guo wx. J Laparoendosc Adv Surg Tech A. 2022 Oct;32(10):1102-1107. doi: 10.1089/lap.2022.0310. Epub 2022 Sep 8. J Laparoendosc Adv Surg Tech A. 2022. PMID: 36074095

6

Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study.

Yang SY, Feng JK, Yan ML, Guo L, Duan YF, Ye JZ, Liu ZH, Xiang YJ, Xu L, Xue J, Shi J, Lau WY, Cheng SQ, Guo WX. Yang SY, et al. Among authors: guo wx. Hepatol Int. 2023 Oct;17(5):1251-1264. doi: 10.1007/s12072-023-10492-2. Epub 2023 Apr 15. Hepatol Int. 2023. PMID: 37060489

7

Short-term and long-term outcomes after robotic versus open hepatectomy in patients with large hepatocellular carcinoma: a multicenter study.

Zhang XP, Jiang N, Zhu L, Lin ZY, Guo WX, Chen X, Ma YT, Zhang F, Tang YF, Chen ZL, Yan ML, Zhao ZM, Li CG, Lau WY, Cheng SQ, Hu MG, Liu R. Zhang XP, et al. Among authors: guo wx. Int J Surg. 2024 Feb 1;110(2):660-667. doi: 10.1097/JS9.0000000000000873. Int J Surg. 2024. PMID: 37983785 Free PMC article.

8

Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.

Zhu HF, Feng JK, Xiang YJ, Wang K, Zhou LP, Liu ZH, Cheng YQ, Shi J, Guo WX, Cheng SQ. Zhu HF, et al. Among authors: guo wx. BMC Cancer. 2023 Jun 15;23(1):547. doi: 10.1186/s12885-023-11003-0. BMC Cancer. 2023. PMID: 37322411 Free PMC article.

9

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase II trial.

Wang K, Yu HM, Xiang YJ, Cheng YQ, Ni QZ, Guo WX, Shi J, Feng S, Zhai J, Cheng SQ. Wang K, et al. Among authors: guo wx. Future Oncol. 2022 Sep;18(30):3367-3375. doi: 10.2217/fon-2022-0188. Epub 2022 Aug 15. Future Oncol. 2022. PMID: 35968836

10

Image-matching digital macro-slide-a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma.

Yu HM, Wang K, Feng JK, Lu L, Qin YC, Cheng YQ, Guo WX, Shi J, Cong WM, Lau WY, Dong H, Cheng SQ. Yu HM, et al. Among authors: guo wx. Hepatol Int. 2022 Apr;16(2):381-395. doi: 10.1007/s12072-022-10307-w. Epub 2022 Mar 16. Hepatol Int. 2022. PMID: 35294742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year